- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: complete response
Total 15831 results
-
Peking University First HospitalRecruitingNeoadjuvant Therapy | Cisplatin | Immunotherapy | HER2-negative Breast Cancer | Pathological Complete Response | VinorelbineChina
-
Gruppo Oncologico del Nord-OvestRecruitingLocally Advanced Basal Cell CarcinomaItaly
-
Ottawa Hospital Research InstituteOntario Institute for Cancer Research; Intensity Therapeutics, Inc.Recruiting
-
Alexandria UniversityNot yet recruiting
-
Wake Forest University Health SciencesNational Cancer Institute (NCI)RecruitingVitamin D Deficiency | Triple Negative Breast Cancer | Invasive Breast CancerUnited States
-
Zhejiang Cancer HospitalNot yet recruitingLocally Advanced Rectal CancerChina
-
Fundacio Clinic BarcelonaRoche Pharma AG; SOLTI Breast Cancer Research GroupRecruitingStage I Breast Cancer | HER2-positive Breast CancerSpain
-
Ruijin HospitalThe First Affiliated Hospital of Anhui Medical University; The First Affiliated... and other collaboratorsRecruitingEsophageal Squamous Cell CarcinomaChina
-
Lund University HospitalDanish Breast Cancer Cooperative Group; Swedish Breast Cancer Group; Finnish... and other collaboratorsRecruitingBreast Cancer | Triple Negative Breast NeoplasmsDenmark, Sweden
-
Jørgen Bjerggaard JensenRecruiting
-
David Garcia CincaFundacion Clinic per a la Recerca BiomédicaNot yet recruiting
-
N.N. Petrov National Medical Research Center of...RecruitingRefusal of Breast Surgery in Patients With Breast Cancer With a cCR After NST and a Confirmed Pathological Complete Response (pCR) Using VAB and SLNBRussian Federation
-
Sixth Affiliated Hospital, Sun Yat-sen UniversitySir Run Run Shaw Hospital; The Third Affiliated Hospital of Kunming Medical...Recruiting
-
The Netherlands Cancer InstituteNot yet recruitingAvoiding Sentinel Lymph Node Biopsy in Breast Cancer Patients After Neoadjuvant Chemotherapy (ASICS)Breast Cancer | Triple Negative Breast Cancer | HER2-positive Breast Cancer | Sentinel Lymph Node
-
Changchun Intellicrown Pharmaceutical Co. LTDRecruiting
-
Maria Sklodowska-Curie National Research Institute...Polish Society of Surgical OncologyRecruitingRectal Cancer | Rectal NeoplasmsPoland
-
Centre Leon BerardRecruitingOsteosarcoma | Ewing Sarcoma | Chondrosarcoma | Leiomyosarcoma | Angiosarcoma | Bone Sarcoma | Undifferentiated Pleomorphic SarcomaFrance
-
Dallas VA Medical CenterRecruitingGastroesophageal Junction Adenocarcinoma | Esophagus Adenocarcinoma | Esophagus Squamous Cell CarcinomaUnited States
-
Centre Georges Francois LeclercRecruiting
-
Jonsson Comprehensive Cancer CenterTesaro, Inc.; Translational Research in Oncology-U.SRecruitingStage IVA Lung Cancer AJCC v8 | Stage IVB Lung Cancer AJCC v8 | Advanced Malignant Solid Neoplasm | Stage III Lung Cancer AJCC v8 | Stage IV Lung Cancer AJCC v8 | Stage IIIA Lung Cancer AJCC v8 | Stage IIIB Lung Cancer AJCC v8 | Extensive Stage Lung Small Cell Carcinoma | Stage IIIC Lung Cancer AJCC v8United States
-
Tianjin Medical University Cancer Institute and...Sun Yat-sen University; Cancer Institute and Hospital, Chinese Academy of Medical... and other collaboratorsNot yet recruitingStage III Esophageal Cancer | Stage II Esophageal Cancer
-
Gustave Roussy, Cancer Campus, Grand ParisRecruitingRelapsing/Refractory ALK+ Anaplastic Large Cell LymphomaFrance, Denmark, Netherlands
-
Yanhong DengRecruiting
-
Hospital JP GarrahanHospital Pereyra Rosell, Montevideo, UruguayRecruitingPediatric Hodgkin's DiseaseArgentina
-
The Netherlands Cancer InstituteDutch Cancer SocietyRecruitingRectal NeoplasmsNetherlands, Belgium
-
Mount Sinai Hospital, CanadaRecruiting
-
Sahlgrenska University Hospital, SwedenKarolinska InstitutetRecruiting
-
Peking University People's HospitalXijing Hospital; Beijing Friendship Hospital; Peking Union Medical College Hospital and other collaboratorsRecruitingRectal Cancer | Pathological Complete Response | Disease Free SurvivalChina
-
The First Hospital of Jilin UniversityFirst Affiliated Hospital Xi'an Jiaotong University; Qingdao University; First... and other collaboratorsRecruiting
-
University of Maryland, BaltimoreVanderbilt UniversityRecruiting
-
Lund UniversitySouth Sweden Breast Cancer Group; Mrs. Berta Kamprad Foundation; U-CANRecruitingBreast NeoplasmsSweden
-
Sun Yat-sen UniversityZhejiang Cancer Hospital; First People's Hospital of Hangzhou; The First Affiliated... and other collaboratorsRecruiting
-
American University of Beirut Medical CenterRecruitingChronic Myelogenous LeukemiaLebanon
-
QuantumLeap Healthcare CollaborativeRecruitingBreast Cancer | Breast Neoplasms | Breast Tumors | HER2-positive Breast Cancer | Angiosarcoma | Locally Advanced Breast Cancer | HER2-negative Breast Cancer | TNBC - Triple-Negative Breast Cancer | Hormone Receptor Positive Tumor | Hormone Receptor Negative Tumor | Early-stage Breast CancerUnited States
-
M.D. Anderson Cancer CenterAriad PharmaceuticalsTerminatedLeukemiaUnited States
-
Centre Jean PerrinConseil National des Etablissements ThermauxActive, not recruitingQuality of Life | Remission | Non-Metastatic Breast CarcinomaFrance
-
Roswell Park Cancer InstituteActive, not recruitingHodgkin Lymphoma | Waldenstrom Macroglobulinemia | Non-Hodgkin Lymphoma | Myelodysplastic Syndrome | Plasma Cell Myeloma | Myeloproliferative Neoplasm | Minimal Residual Disease | Graft Versus Host Disease | Severe Aplastic Anemia | Acute Myeloid Leukemia in Remission | Adult Acute Lymphoblastic Leukemia... and other conditionsUnited States
-
AstraZenecaMerck Sharp & Dohme LLC; GOG Foundation; Myriad Genetic Laboratories, Inc.Active, not recruitingAdvanced Ovarian Cancer | Newly Diagnosed | FIGO Stage III-IV | Partial Response | Complete Response | BRCA Mutation | First Line Platinum ChemotherapyKorea, Republic of, France, Italy, United States, Israel, Canada, China, Brazil, United Kingdom, Poland, Australia, Japan, Netherlands, Russian Federation, Spain
-
M.D. Anderson Cancer CenterActive, not recruitingAcute Lymphoblastic Leukemia | Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive | Philadelphia Chromosome Positive | B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1 | Untreated Adult Acute Lymphoblastic Leukemia | Accelerated Phase Chronic Myelogenous Leukemia,... and other conditionsUnited States
-
University of BirminghamActive, not recruiting
-
OHSU Knight Cancer InstituteNational Cancer Institute (NCI); Genentech, Inc.; Oregon Health and Science University and other collaboratorsTerminatedCentral Nervous System B-Cell Non-Hodgkin LymphomaUnited States
-
AstraZenecaActive, not recruitingRelapsed Ovarian Cancer | Following Complete or Partial Response to Platinum Based Chemotherapy | Platinum SensitiveChina, Malaysia
-
Lucia Del Mastro,MDCompleted
-
Kyowa Kirin Co., Ltd.Kyowa Hakko Kirin Pharma, Inc.CompletedCutaneous T-cell Lymphoma | Peripheral T-cell LymphomaUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedAnatomic Stage IIB Breast Cancer AJCC v8 | Anatomic Stage III Breast Cancer AJCC v8 | Anatomic Stage IIIA Breast Cancer AJCC v8 | Anatomic Stage IIIB Breast Cancer AJCC v8 | Anatomic Stage IIIC Breast Cancer AJCC v8 | Prognostic Stage IIB Breast Cancer AJCC v8 | Prognostic Stage III Breast Cancer... and other conditionsUnited States
-
AstraZenecaMerck Sharp & Dohme LLC; European Network of Gynaecological Oncological Trial... and other collaboratorsActive, not recruitingRelapsed Ovarian Cancer | Following Complete or Partial Response to Platinum Based Chemotherapy | Platinum Sensitive | BRCA MutatedKorea, Republic of, France, China, Italy, United States, Israel, United Kingdom, Canada, Japan, Germany, Brazil, Netherlands, Belgium, Poland, Australia, Russian Federation, Spain
-
AbbVieActive, not recruiting
-
University of New MexicoCompletedInsulin Resistance | Type 2 DiabetesUnited States
-
Centre Hospitalier Universitaire DijonTerminatedEpidermoid Carcinoma or | Adenocarcinoma of the Thoracic Oesophagus or | Adenocarcinoma of the Oesogastric Junction (Siewert Type I or II) | Stage cT2 N1-3 M0 or cT3-T4a N0 or N1-3 M0France